Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer’s disease mice model
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases which seriously affect the quality of life of the elderly. Schisandrin (SCH) and nootkatone (NKT) are the two marked active components in ASHP. In this study, the effects of Alpinia oxyphylla—Schisandra chinensis herb pair (ASHP) as well as its bioactive components on cognitive deficiency and dementia were revealed via Aβ1–42-induced AD in mouse. Morris water maze test showed that acute administration of ASHP and SCH + NKT treatments had higher discrimination index in the object recognition task, more quadrant dwell time and shorter escape latency compared with those in the Morris water maze. The levels of TNF-α, IL-1β and IL-6 were decreased after ASHP and SCH + NKT treatment. The inflammatory response was attenuated by inhibiting TLR4/ NF-κB/ NLRP3 pathway. In addition, ASHP and SCH + NKT treatments significantly restored the activities of superoxide dismutase (SOD), glutathione S-transferase (GST), cyclooxygenase-2 (COX-2), total antioxidant capacity (T-AOC) and inducible nitric oxide syntheses (iNOS), and the levels of glutathione (GSH), malondialdehyde (MDA) and nitric oxide (NO). The histopathological changes of hippocampus were noticeably improved after ASHP and SCH + NKT treatments. These findings demonstrate that ASHP as well as its bioactive components exerted a protective effects on cognitive disorder, inflammatory reaction and oxidative stress.
KeywordsAlzheimers’ disease Cognitive dysfunction Inflammation Oxidation Schisandrin Nootkatone
This study was supported by the National Natural Science Foundation of China (no. 81573580). Key laboratory of polysaccharide bioactivity evaluation of TCM of Liaoning Province. Key techniques study of consistency evaluation of drug quality and therapeutic effect (18-400-4-08) and Liaoning Distinguished Professor Project for Ying Jia (2017).
Compliance with ethical standards
Conflict of interest
The authors have no conflict of interest to declare.
- BRYAN D, DEVAN EHG (1996) Dissociation of hippocampal and striatal contributions to spatial navigation in the water maze. Neurobiol Learn Mem 66Google Scholar
- Butterfield, D.A., 2018. Perspectives on oxidative stress in Alzheimer's disease and predictions of future research emphases. Journal of Alzheimers Disease 1–11Google Scholar
- Contedaban A, Ambike V, Régis Guillot, et al., (2018) A metallo pro-drug to target cu(II) in the context of Alzheimer's disease. Chemistry 24:5095–5099Google Scholar
- Di, H., et al., 2012. Schizandrin, an Antioxidant Lignan from Schisandra chinensis, Ameliorates Aβ1–42-Induced Memory Impairment in Mice. Oxidative Medicine and Cellular Longevity,2012,(2012-5-22). 2012, 721721Google Scholar
- Dubinina EE, Pustygina AV (2007) Free radical processes in aging, neurodegenerative diseases and other pathological states. Biochemistry Supplement 1:284–298Google Scholar
- Eslami SM, Ghasemi M, Bahremand T, Momeny M, Gholami M, Sharifzadeh M, Dehpour AR (2017) Involvement of nitrergic system in anticonvulsant effect of zolpidem in lithium-pilocarpine induced status epilepticus: evaluation of iNOS and COX-2 genes expression. Eur J Pharmacol 815:454–461PubMedGoogle Scholar
- Gustaw-Rothenberg KA, Lerner A, Perry G, Siedlak SL, Zhu X, Smith MA (2010) MDA and GSH levels in newly diagnosed Alzheimer's disease patients: a population-based study. Alzheimers & Dementia the Journal of the Alzheimers Association 6:S510–S511Google Scholar
- Lee HG et al (2006) Amyloid-beta toxicity in Alzheimer disease: the null versus the alternate hypotheses. In: Biennial Meeting of the Asian-Pacific-Society-For-Neurochemistry, pp 12–12Google Scholar
- Malashenkova IK, Khailov NA, Krynskii SA, Ogurtsov DP, Kazanova GV, Velichkovskii BB, Selezneva ND, Fedorova YB, Ponomareva EV, Kolykhalov IV, Gavrilova SI, Didkovskii NA (2017) Levels of proinflammatory cytokines and vascular endothelial growth factor in patients with Alzheimer's disease and mild cognitive impairment. Neurosci Behav Physiol 47:694–698Google Scholar
- Miao J et al (2010) Clinical studies with traditional Chinese medicine in the past decade and future research and development. Planta Med 76:2048Google Scholar
- Nuray N, Ulusu MS, Avci A, Canbolat O, Ozansoy G, Ari N, Bali M, Stefek M, Stolc S, Gajdosik A, Karasu Ç (2003) Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of Stobadine and vitamin E. Neurochem Res 28:815–823Google Scholar
- Richardson JS (2010) Free radicals in the genesis of Alzheimer's disease. Ann N Y Acad Sci 695:73–76Google Scholar
- Song JX et al (2015) Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells. Phytother Res 25:435–443Google Scholar
- Zhang GX et al (2013) [the role of TLR4-mediated MyD88-dependent pathway in neuroinflammation in hippocampal neurons of rats]. Chinese. J Appl Physiol 29:42Google Scholar